Trial completion • Trial completion date • Metastases
|
PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • PGR (Progesterone receptor) • PTEN (Phosphatase and tensin homolog) • CTNNB1 (Catenin (cadherin-associated protein), beta 1)
|
KRAS mutation • PIK3CA mutation • MTOR mutation
|
everolimus • tamoxifen • letrozole